Fasting on Newly Diagnosed Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: HER2-positive Breast Cancer
Interventions: DRUG: Doxorubicin|DRUG: cyclophosphamide|DRUG: paclitaxel|DRUG: docetaxel|DRUG: Trastuzumab|DRUG: Pertuzumab
Sponsor: Western Regional Medical Center